直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Ad Law Buzz Blog

Beyond Litigation: Pushing Back on Competitors’ False Advertising Using Self-Regulation

December 27, 2024

It's a dilemma that most marketers face at one point or another: a competitor runs an ad that isn't quite aboveboard. Maybe the ad overstates a product’s performance. Maybe it asserts superiority without appropriate substantiation. A first thought might be litigation. But unseating false claims, while important, does not always warrant the time and expense of litigation. 

In these instances, many companies choose to take on competitors’ ads using the advertising industry’s self-regulatory forum. The National Advertising Division (“NAD”), an industry-backed dispute resolution body that operates as part of BBB National Programs, has reviewed thousands of ad campaigns over the past 50+ years for truth, accuracy, and compliance with advertising law. As a faster and less expensive alternative to litigation, NAD has become the default dispute resolution forum for advertisers in many industries. 

In 2023, for example, NAD issued 126 decisions—45 in the telecommunications sector, 14 in the food and beverage sector, and dozens more in categories including household products, health products, financial services, sports, jewelry, and many others. The vast majority of these disputes are initiated when one competitor seeks to do away with another’s claims. (The others are initiated by NAD itself pursuant to its “monitoring” function.) 

Not surprisingly, many of the challenged claims are comparative in nature—as in, “Toothpaste X whitens teeth twice as well as Toothpaste Y.” But NAD’s scope of review extends beyond comparative advertising. Competitors can challenge one another’s sensory claims, performance claims, ingredient claims, environmental claims, “Made in USA” claims, technical claims, and more.

The challenge process moves quickly with each party submitting two written briefs followed by a meeting with NAD. Generally, within eight months of filing a challenge, NAD publishes its decision.  

NAD differs from litigation in several important respects. One notable difference is that the NAD process is voluntary. NAD issues “recommendations” rather than binding decisions. Technically, companies that are called upon to participate are free to opt out. And technically, even after submitting to NAD’s jurisdiction, companies are free to ignore its recommendations. That said, blowing off NAD comes with consequences; NAD issues press releases announcing non-compliance and non-participation, and NAD refers these companies to the “appropriate governmental agency” (normally the FTC) for further review. Ignoring NAD may also bode poorly for a company’s future reliance on the forum as a tool for initiating a company’s own challenges. For these reasons, NAD’s compliance rate is extremely high, hovering at 90-95%. 

Of course, the self-regulatory process is just one of many tools that keep competitors’ advertising in line. Demand letters can sometimes be effective. Litigation can also be a reasonable approach. Sometimes companies respond by launching a counter-offensive ad campaign of their own. For many companies, however, the NAD process offers a quick and relatively low-cost method for keeping competitors in line. 

 

Tags

false advertising, National Advertising Division (NAD)

Related Practices

Trademark and Brand Management

Advertising

Related Industries

Communications

Consumer Goods and Services

Food and Beverage

Consumer Products

Related Offices

Washington, DC

Related Professionals

Jennifer E. Fried
Partner
Washington, DC
+1 202 408 4166
Email

Copyright © 2024 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

Panel Discussion

Global Patent Strategies & Litigation: An Exclusive Off-the-Record Conversation with Experienced In-House Leaders

May 5, 2026

London

Conference

International Trade Commission Litigation & Enforcement

May 4-5, 2026

Washington, DC

Articles

D. Mass. Patent Litigation Update, March 2026

D. Mass. Patent Litigation Update: March 2026

May 4, 2026

Ad Law Buzz Blog

How to Survive a Section 230 Defense: Recent Cases Provide Guidance

May 1, 2026

Articles

TOPCon v. Back-Contact Solar Cells: The Technology Race Fueled by Patent Strategy, Enforcement and Licensing

April 27, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP